Skip to content

Clinical trials

Lupus Erythematosus, Systemic trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Country / region: Sweden Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20111
20121
20132
20151
20201
20211
20223
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting6
Active, not recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
AstraZeneca2
Biogen2
Human Genome Sciences Inc., a GSK Company2
Karolinska Institutet2
Novartis Pharmaceuticals2
Active Biotech AB1
Bristol-Myers Squibb1
Fate Therapeutics1
Human Genome Sciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic19
Autoimmune Diseases6
Lupus Nephritis5
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Fatigue1
Immune System Diseases1
Lupus Erythematosus, Cutaneous1
Lupus Erythematosus, Discoid1
Myositis1
Scleroderma, Systemic1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.